Synthesis,structure, and urease inhibitory activities of Co(III), Mn(II) and Zn(II) complexes with hydrazone derived from protocatechuic acid

[Co^III(L₁)₂·H₂O]NO₃ (1), [Mn^II(L₁)₂·H₂O] (2), and [Zn^II(L₁)₂·H₂O] (3) with a hydrazone derived from protocatechuic acid (HL₁ = C₁₅H₁₃N₃O₃) were designed, synthesized, and characterized by C, H, N elemental analyses, single-crystal X-ray diffraction, and IR spectra, which revealed that the three complexes are similar structures. Docking study has been done. The urease inhibitory activities of the three complexes were tested. Complexes 1 and 3 showed strong inhibitory activity against jack bean urease with IC₅₀ values of 45.9 and 11.64 μM. Complex 2 had no obvious inhibitory activity to urease; the IC₅₀ was > 50 μM.     

Syntheses,characterization, in vitro antiglycation and DPPH radical scavenging activities of isatin salicylhydrazidehydrazone and its Mn (II), Co (II), Ni (II), Cu (II), and Zn (II) metal complexes

2-Hydroxy salicylhydrazide isatin hydrazone (L) and its Mn (II), Co (II), Ni (II), Cu (II), and Zn (II), metal complexes were synthesized. ¹H NMR, UV–Vis, IR spectroscopy and elemental (CHN/S) analysis techniques were applied for characterization. TG/DTA techniques revealed that all the synthetic compounds are thermally stable up to 300 °C. They were found non-electrolytes in nature. Furthermore, all these complexes were evaluated for antiglycation and DPPH radical scavenging activities. They showed varying degree of activity with IC₅₀ values between 168.23 and 269.0 μM in antiglycation and 29.63–57.71 μM in DPPH radical scavenging activity. Mn (II), Co (II), Ni (II), Cu (II), and Zn (II), metal complexes showed good antiglycation as well as DPPH radical scavenging activity. The IC₅₀ values for antiglycation activity are 168.23 ± 2.37, 234.27 ± 4.33, 257.1 ± 6.43, 267.7 ± 8.43, 269.0 ± 8.56 Ni for Co, Zn, Mn, Cu, and Ni complexes, respectively, while IC₅₀ value were found to be 29.63 ± 2.76, 31.13 ± 1.41, 35.16 ± 2.45, 43.53 ± 3.12, 57.71 ± 2.61 μM for Cu, Zn, Mn, Co and Ni complexes, respectively, for DPPH radical scavenging activity. These synthesized metal complexes were found to be better active than standards Rutin (IC₅₀ = 294.46 μM) for anti-glycation, and tert-butyl-4-hydroxyanisole (IC₅₀ = 44.7 μM) for DPPH radical scavenging activity.     

Synthesis,structure, and biological evaluation of three Cu(II) and Ni(II) (E)-3-(3,4-dimethoxyphenyl)acrylate complexes with organic diamines as potential urease inhibitors

Three new complexes (1–3) have been synthesized and characterized by X-ray single crystal determination and evaluated for inhibitory activity on jack bean urease. All the complexes contained a new cinnamic acid derivative as the ligand (C₁₁H₁₂O₄), (E)-3-(3,4-dimethoxyphenyl)acrylic acid, and crystallized in monoclinic C2/c space group. Complex 1 (C₁₁H₁₁O₄)₄(C₃N₂H₈)₂Cu₂ (C₃N₂H₈?=?1,2-diaminopropane) was obtained with a?=?20.488(2), b?=?19.596(2), c?=?15.2500(13), β?=?93.502(2)°, V?=?6111.2(10)?ų, Z?=?4, R ₁ ?=?0.0616, and wR ₂ ?=?0.2059. Complex 2 (C₁₁H₁₁O₄)₄(C₃N₂H₈)₂Cu₂ (C₃N₂H₈=1,3-diaminopropane) was obtained with a?=?20.2494(12), b?=?19.5732(12), c?=?14.8940(8), β?=?96.884(2)°, V?=?5860.6(6)?ų, Z?=?4, R ₁ ?=?0.0409, and wR ₂ ?=?0.1107. Complex 3 (C₁₁H₁₁O₄)₂(C₂N₂H₆)₂Ni₂·H₂O (C₂N₂H₆?=?ethylenediamine) was obtained with a?=?28.359(2), b?=?6.5422(5), c?=?16.8587(14), β?=?101.359(2)°, V?=?3066.5(4)?ų, Z?=?4, R ₁ ?=?0.0422, and wR ₂ ?=?0.1190. It was found that copper(II) complexes 1 [IC₅₀?=?4.71?μM] and 2 [IC₅₀?=?3.15?μM] showed strong inhibitory activity against jack bean urease compared with acetohydroxamic acid [IC₅₀?=?10.01?μM] as a positive reference. Unfortunately, 3 exhibited no inhibitory activity.     

Synthesis,crystal structures,and urease inhibition studies of two new Schiff-base copper complexes derived from n-butylamine

Two Schiff-base copper(II) complexes, bis(N-n-butyl-5-chlorosalicylaldiminato) copper(II) (1) and bis(N-n-butyl-4-methoxysalicylaldiminato) copper(II) (2), were synthesized and their solid-state structures were determined by X-ray crystallography. Complex 1 displays a distorted square-planar geometry, while 2 possesses square-planar geometry. Copper(II) complexes 1 and 2 showed strong inhibitory activity against jack bean urease (IC₅₀?=?2.7, 3.5?µmol?L^?1), compared with acetohydroxamic acid (IC₅₀?=?63.00?µmol?L^?1). A molecular modeling study was carried out via the DOCK program to gain understanding of the potent inhibitory activity of these copper species against jack bean urease.     

Syntheses,urease inhibition activities,and fluorescent properties of transition metal complexes

Four transition metal complexes with Schiff base and 1,10-phenanthroline, [Cu(L)(phen)]₂·C₂H₅OH (1), [Zn(L)(phen)]₂·C₂H₅OH (2), [Ni(L)(phen)]₂·C₂H₅OH (3), and [Co(L)(phen)]₂·C₂H₅OH (4) (H₂L?=?1-((2-hydroxynaphthalen-1-yl)methylene)thiosemicarbazide; phen?=?1,10-phenanthroline) were synthesized and characterized by physico-chemical methods. The crystal structure of 1 was determined by X-ray single-crystal diffraction analysis. 1 crystallizes in the orthorhombic space group Pbca with a?=?15.008(9), b?=?16.100(10), c?=?37.54(2)?Å, V?=?9070(10)?ų, Z?=?8, GOOF?=?1.002, R ₁?=?0.0626, and wR ₂?=?0.0912. The fluorescence and urease inhibitory activities of the compounds were tested. The enzymatic activity study indicated that 3 possessed potent inhibition against jack bean urease, with IC₅₀?=?1.2?±?0.1?μM, and about 35 times more than 42.1?±?0.4 acetohydroxamic acid as positive reference. This suggests that inhibitory efficiency of these complexes can be strongly influenced by different transition metal ions.     

Synthesis,Structural, Biological Evaluation,Molecular Docking and DFT Studies of Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and Hg(II) Complexes bearing Heterocyclic Thiosemicarbazone ligand

A new ligand, 2‐aminonicotinaldehyde N‐methyl thiosemicarbazone (ANMTSC) and its metal complexes [Co(II) ( 1 ); Ni(II) ( 2 ); Cu(II) ( 3 ); Zn(II) ( 4 ); Cd(II) ( 5 ) or Hg(II) ( 6 )] were synthesized. The compounds were characterized by analytical methods and various spectroscopic (infrared, magnetic, thermal, ¹H, ¹³C NMR, electronic and ESR) tools. The structure of ANMTSC ligand was confirmed by single crystal X‐ray diffraction study. The spectral data of metal complexes indicate that the ligand acts as mononegative, bidentate coordination through imine nitrogen (N) and thiocarbonyl sulphur (S^?) atoms. The proposed geometries for complexes were octahedral ( 1 – 2 ), distorted octahedral ( 3 ) and tetrahedral ( 4 – 6 ). Computational details of theoretical calculations (DFT) of complexes have been discussed. The compounds were subjected to antimicrobial, antioxidant, antidiabetic, anticancer, ROS, studies and EGFR targeting molecular docking analysis. Complex 5 has shown excellent antibacterial activity and the complexes 2 and 5 have shown good antifungal activity. The complexes 1 and 4 displayed good antioxidant property with IC₅₀ values of 11.17 ± 1.92 μM and 10.79 ± 1.85 μM, respectively compared to standard. In addition, in vitro anticancer activity of the compounds was investigated against HeLa, MCF‐7, A549, IMR‐32 and HEK 293 cell lines. Among all the compounds, complex 4 was more effective against HeLa (IC₅₀ = 10.28 ± 0.69 μM), MCF‐7 (IC₅₀ = 9.80 ± 0.83 μM), A549 (IC₅₀ = 11.08 ± 0.57 μM) and IMR‐32 (10.41 ± 0.60 μM) exhibited superior anticancer activity [IC₅₀ = 9.80 ± 0.83 ( 4 ) and 9.91 ± 0.37 μM ( 1 )] against MCF‐7 compared with other complexes.     

Synthesis,characterization and anticancer studies of bis-(N-methyl-1-phenyldithiocarbamato) Cu(II), Zn(II), and Pt(II) complexes: single crystal X-ray structure of the copper complex

Abstract

Cu(II), Pt(II), and Zn(II) complexes of N-methyl-1-phenyldithiocarbamate were synthesized and characterized by FTIR, NMR, UV-visible spectroscopy and elemental analysis. The complexes were formulated as [Cu(L)₂], [Zn(L)₂] and [Pt(L)₂] (where L?=?N-methyl-1-phenyldithio­carbamate) in which two molecules of the ligands coordinate to the metal ions in a bidentate chelating fashion. This is confirmed by elemental analysis and the presence of strong single bands at 952, 951, and 955?cm^?1 for Cu(II), Pt(II), and Zn(II) complexes, respectively, in the FTIR spectra. The electronic spectra of Pt(II) and Cu(II) complexes are consistent with four-coordinate square planar geometry. Single crystal X-ray of [Cu(N-mpDTC)₂] confirmed square planar structural arrangement (CuS₄) in which the ligands are asymmetrically bonded to the Cu(II) ion building a centrosymmetric monomer entity. The S-Cu-S bite angle is 77.95° (3) whereas the intramolecular N–C bond length is 1.318 Å and trans S1¹-Cu-S1?=?S2¹-Cu-S2 is 180°, which are consistent with reported copper thiolates in square planar environment. In vitro antiproliferative activity of the complexes against three human cancer cell lines showed that the zinc complex has better activity compared to Cu and Pt complexes, with IC₅₀ values of 14.28, 22.74 and 20.10?μM against TK10, UACC62, and MC7 cell lines, respectively.     

Spectral,thermal and magnetic investigations of Mn(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) 4-methylphthalates

Conditions for the preparation of Mn(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) 4-methylphthalates were investigated and their composition, solubility in water at 295 K and magnetic moments were determined. IR spectra and powder diffraction patterns of the complexes prepared with molar ratio of metal to organic ligand of 1.0:1.0 and general formula: M [ CH₃C₆H₃(CO₂)₂]·nH₂o (n=1-3) were recorded and their decomposition in air were studied. During heating the hydrated complexes are dehydrated in one (Mn, Co, Ni, Zn, Cd) or two steps (Cu) and next the anhydrous complexes decompose to oxides directly (Cu, Zn), with intermediate formation of carbonates (Mn, Cd), oxocarbonates (Ni) or carbonate and free metal (Co). The carboxylate groups in the complexes studied are mono- and bidentate (Co, Ni), bidentate chelating and bridging (Zn) or bidentate chelating (Mn, Cu, Cd). The magnetic moments for paramagnetic complexes of Mn(II), Co(II), Ni(II) and Cu(II) attain values 5.92, 5.05, 3.36 and 1.96 M.B., respectively. This revised version was published online in July 2006 with corrections to the Cover Date.     

New Complexes of Mn(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) with 3,3-dimethylglutaric Acid

Conditions for the preparation of Mn(II), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II)3,3-dimethylglutarates were investigated and their quantitative composition, solubility in water at 293 K and magnetic moments were determined. IR spectra and powder diffraction patterns of the complexes prepared with general formula MC₇H₁₀O₄⋅nH₂O (n=0−2) were recorded and their thermal decomposition in air were studied. During heating the hydrated complexes of Mn(II),Co(II), Ni(II) and Cu(II) are dehydrated in one step and next all the anhydrous complexes decompose to oxides directly (Mn, Co, Zn) or with intermediate formation free metal (Ni,Cu) or oxocarbonates (Cd). The carboxylate groups in the complexes studied are bidentate. The magnetic moments for the paramagnetic complexes of Mn(II), Co(II), Ni(II) and Cu(II)attain values 5.62, 5.25, 2.91 and 1.41 M.B., respectively. This revised version was published online in August 2006 with corrections to the Cover Date.     

Heteronuclear complexes of oxorhenium(V) with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO2(VI) and their biological activities

Heteronuclear complexes containing oxorhenium(V), with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO₂(VI) ions were prepared by the reaction of the complex ligands [ReO(HL¹)(PPh₃)(OH₂)Cl]Cl (a) and/or [ReO(H₂L²)(PPh₃)(OH₂)Cl]Cl (b), where H₂L¹?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(5,6-diphenyl-1,2,4-triazine-3-ylhydrazone) and H₃L²?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(1H-benzimidazol-2-ylhydrazone), with transition and actinide salts. Heterodinuclear complexes of ReO(V) with Fe(III), Co(II), Ni(II), Cu(II) and Cd(II) were obtained using a 1?:?1 mole ratio of the complex ligand and the metal salt. Heterotrinuclear complexes were obtained containing ReO(V) with UO₂(VI) and Cu(II) using 2?:?1 mole ratios of the complex ligand and the metal salts. The complex ligands a and b coordinate with the heterometal ion via a nitrogen of the heterocyclic ring and the nitrogen atom of the C=N⁷ group. All transition metal cations in the heteronuclear complexes have octahedral configurations, while UO₂(VI)?complexes have distorted dodecahedral geometry. The structures of the complexes were elucidated by IR, ESR, electronic and ¹H NMR spectra, magnetic moments, conductance and TG-DSC measurements. The antifungal activities of the complex ligands and their heteronuclear complexes towards Alternaria alternata and Aspergillus niger showed comparable behavior with some well-known antibiotics.     

Synthesis,structural studies and bio-activity of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) complexes with p -amino acetophenone salicyloyl hydrazone

Complexes of the type [M(pash)Cl] and [M(Hpash)(H₂O)SO₄] (M=Mn(II), Co(II), Ni(II), Cu(II) and Zn(II); Hpash = p-amino acetophenone salicyloyl hydrazone) have been synthesized and characterized by elemental analyses, molar electrical conductance, magnetic moments, electronic, ESR and IR spectra, thermal studies and X-ray powder diffraction. All the complexes are insoluble in common organic solvents and are non-electrolytes. The magnetic moment values and electronic spectra indicate a square-planar geometry for Co(II), Ni(II) and Cu(II) chloride complexes and spin-free octahedral geometry for the sulfato complexes. The ligand coordinates through >C=N–,–NH₂ and a deprotonated enolate group in all the chloro complexes, and through >C=N–, >C=O and–NH₂ in the sulfato complexes. Thermal analyses (TGA and DTA) of [Cu(pash)Cl] show a multi-step exothermic decomposition pattern. ESR spectral parameters of Cu(II) complexes in solid state at room temperature suggest the presence of the unpaired electron in d _{x ² ? y ²} . X-ray powder diffraction parameters for [Cu(pash)Cl] and [Ni(Hpash)(H₂O)SO₄] correspond to tetragonal and orthorhombic crystal lattices, respectively. The complexes show a fair degree of antifungal activity against Aspergillus sp., Stemphylium sp. and Trichoderma sp. and moderate antibacterial activity against E. coli and Clostridium sp.     

Spectrothermal studies on Co(II), Ni(II), Cu(II) and Zn(II) salicylato (1,10-phenanthroline) complexes

The cobalt, nickel, copper and zinc atoms in bis(1,10-phenanthroline)bis(salicylato-O)metal(II) monomeric octahedral complexes [M(Hsal)₂(phen)₂]·nH₂O, (M: Co(II), n=1; Cu(II), n=1.5 and Ni(II), Zn(II), n=2) are coordinated by the salicylato monoanion (Hsal) through the carboxyl oxygen in a monodentate fashion and by the 1,10-phenanthroline (phen) molecule through the two amine nitrogen atoms in a bidentate chelating manner. On the basis of the DTG_max, the thermal stability of the hydrated complexes follows order: Ni(II) (149°C)>Co(II) (134°C)>Zn(II) (132°C)>Cu(II) (68°C) in static air atmosphere. In the second stage, the pyrolysis of the anhydrous complexes takes place. The third stage of decomposition is associated with a strong exothermic oxidation process (DTA curves: 410, 453, 500 and 450°C for the Co(II), Ni(II), Cu(II) and Zn(II) complexes, respectively). The final decomposition products, namely CoO, NiO, CuO and ZnO, were identified by IR spectroscopy. This revised version was published online in July 2006 with corrections to the Cover Date.     

Synthesis,crystal structures and Jack bean urease inhibitory activity of copper(II) complexes with 4-bromo-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide

A new hydrazone 4-bromo-N′-(2-hydroxy-5-methoxybenzylidene)benzohydrazide (HL) was prepared and characterized by infrared and UV–vis spectra, as well as single-crystal X-ray diffraction. With the hydrazone as ligand, two new copper(II) complexes were prepared, [Cu₂L₂(NCS)₂]·4H₂O (1) and [CuBrL]·CH₃OH (2). The complexes were characterized by infrared and UV–vis spectra, and single-crystal X-ray diffraction. The Cu in 1 is in a square pyramidal coordination geometry and that in 2 is in a square planar coordination geometry. The two complexes show effective Jack bean urease inhibitory activity, with IC₅₀ values of 23.5 and 2.7 μM, respectively. A molecular docking study of 2 with the urease was performed. The relationship between the structure and urease inhibitory activity indicated that copper complex with square planar coordination is a better model for urease inhibition.     

Synthesis,characterization, and biological activities of a Cu(II) complex with the non-steroidal antiinflammatory drug flufenamic acid

[Cu^II(L)₂.C₁₂H₁₀N₂] with flufenamic acid (HL=C₁₄H₁₀F₃NO₂) and phenanthroline (C₁₂H₁₀N₂O) was synthesized and characterized by C, H and N elemental analysis, single-crystal X-ray diffraction and, IR spectra. The urease inhibitory and antibacterial activities of the complex were tested. The complex showed strong inhibitory activity against jack bean urease with an IC₅₀ value of 0.265 μM. Four bacteria, Bacillus subtilis, Escherichia coli, Staphylococcus aureus, and proteusbacillus vulgaris, were used in the antibacterial test. The complex showed strong inhibitory activity against the species with IC₅₀ values of 2.016, 35.037, 10.680, and 3.820 μM. The interactions of the complex with human serum albumin (HSA) were studied through fluorescence spectroscopy. By analyzing the experimental data, we concluded that the fluorescence quenching mechanism of the complex with serum albumin was static quenching. The binding mode of the complex with DNA through UV spectroscopy was electrostatic binding or groove.     

Syntheses,crystal structures,and Jack bean urease inhibitory activities of copper(II) complexes derived from 4-tert-butyl-N′-(1-(pyridin-2-yl)ethylidene)benzohydrazide

Two new copper(II) complexes, [CuL(HL)]·ClO₄ (1) and [Cu₂Br₂L₂]·0.85H₂O (2), where L is the monoanionic form of 4-tert-butyl-N′-(1-(pyridin-2-yl)ethylidene)benzohydrazide (HL), have been prepared. The complexes were characterized by infrared and UV–vis spectra, and single crystal X-ray diffraction. Complex 1 is a mononuclear copper(II) species and 2 is a bromido-bridged dinuclear copper(II) species. The Cu ion in 1 is in an octahedral coordination mode and that in 2 is trigonal-bipyramidal. The Jack bean urease inhibitory assay indicated that 2 is active, with IC₅₀ value of 20.6 ± 2.3 μmol L^?1, while 1 is inactive. Molecular docking of 2 with Jack bean urease was studied.     

Synthesis and characterization of manganese(II), nickel(II), copper(II) and zinc(II) Schiff-base complexes derived from 1,10-phenanthroline-2,9-dicarboxaldehyde and 2-mercaptoethylamine

The synthesis of a new Schiff base containing 1,10-phenanthroline-2,9-dicarboxaldehyde and 2-mercaptoethylamine is described. The reaction of 1,10-phenanthroline-2,9-dicarboxaldehyde with 2-mercaptoethylamine leads to 2,9-bis(2-ethanthiazolinyl)-1,10-phenanthroline (I) which undergoes rearrangement when reacted with manganese, nickel, copper or zinc ions to produce complexes of the tautomeric Schiff base 2,9-bis[2-(2-mercaptoethyl)-2-azaethene]-1,10-phenanthroline (L). The [M(L)Cl₂] complexes [where M = Mn(II), Ni(II), Cu(II) and Zn(II) ions] were characterized by physical and spectroscopic measurements which indicated that the ligand is a tetradentate N₄ chelating agent.     

Synthesis,biological evaluation and molecular docking studies of novel 2-(2-cyanophenyl)-N-phenylacetamide derivatives

A series of novel 2-(2-cyanophenyl)-N-phenylacetamide derivatives 3(a-u) were designed and synthesized via selective amidation of methyl-2-(2-cyanophenyl)acetates over amidine formation by using AlMe₃ as catalyst in good yields. All the newly synthesized derivatives were well characterized by ¹H NMR, ¹³C NMR, FTIR and HRMS spectral techniques. All the synthesized title compounds were evaluated for their in vitro anticancer activity against three cancer cell lines. Among all compounds, 3i (IC₅₀?=?1.20 μM, IC₅₀?=?1.10 μM), 3j (IC₅₀?=?0.11 μM, IC₅₀?=?0.18 μM), 3o (IC₅₀?=?0.98 μM, IC₅₀?=?2.76 μM) showed excellent inhibitory activity than the standard Etoposide (IC₅₀?=?2.11 μM, IC₅₀?=?3.08 μM) against MCF-7 and A-549 cell lines, respectively. Docking analysis of all the compounds with the human topoisomerase II revealed that the compound 3j fitted well in the active site pocket, showing the best docking score of 158.072 kcal/mol.

     

Synthesis,Crystal Structures,and Urease Inhibitory Activities of Three Novel Thiocyanato‐bridged Polynuclear Schiff Base Cadmium(II) Complexes

Three novel thiocyanato‐bridged polynuclear cadmium(II) complexes, [Cd(HL1)(NCS)₂(μ_1,3‐NCS)]_n ( 1 ), [CdL2(μ_1,3‐NCS)₂]_n ( 2 ), and [CdL3(μ_1,3‐NCS)₂]_n ( 3 ) (L1 = N‐methyl‐N′‐(1‐pyridin‐2‐ylmethylidene)ethane‐1,2‐diamine, L2 = 2‐(cyclopropyliminomethyl)‐6‐methoxyphenol, L3 = 2‐(cyclopentyliminomethyl)‐6‐methoxyphenol), have been synthesized and structurally characterized by elemental analysis, IR spectra and single‐crystal X‐ray diffraction. Each cadmium(II) atom in the complexes is in an octahedral coordination. The urease inhibitory activities of the complexes were evaluated. All of them showed potent inhibitions against jack bean urease.     

Synthesis,characterization, and urease inhibitory activity of two copper(II) complexes of cyclohexanecarboxylate

The crystal structures of two copper(II) complexes of the cyclohexanecarboxylate ligand, namely [Cu(C₆H₁₁CO₂)₂(H₂O)₂]·H₂O (1) and [Cu(dpyam)₂(C₆H₁₁CO₂)](NO₃)·H₂O (2) (C₆H₁₁CO₂H = cyclohexanecarboxylic acid; dpyam = di-2-pyridylamine), have been determined by single-crystal X-ray analysis. Complex 1 contains the square-planar trans-CuO₄ chromophore, while 2 shows the square pyramidal cis-distorted octahedral CuN₄OO′ chromophore. Both complexes were found to show strong inhibitory activity against jack bean urease (IC₅₀ = 1.75 and 8.57 μM for 1 and 2, respectively), when compared with acetohydroxamic acid (IC₅₀ = 63.12 μM).     

Synthesis,solid-state structures,and urease inhibition activities of new copper(II) complexes based on O,N,O-tridentate Schiff bases

Six new complexes of copper(II) coordinated with O,N,O-tridentate Schiff base dianions were synthesized and structurally characterized. The solid-state structures of 1–6 contain four-coordinate mononuclear copper(II) units with a slightly distorted square planar geometry. Complexes 1 and 4 derived from d-tyrosine have an infinite 1-D, right-handed helical chain, while 5 derived from l-tyrosine has an infinite 1-D, left-handed helical chain. Inhibitions of jack bean urease by 1–6 have been investigated, and potent inhibitory activities with IC₅₀ range of 2.15 ± 0.11–32.12 ± 0.65 μM have been observed for these copper(II) complexes. A docking analysis using a DOCK program was conducted to position 4 into the jack bean urease active site to determine the probable binding conformation.